Company: EDSA
Filing Date: 2025-03-11
Form Type: 424B3
Source: 0001171843-25-001403
Chunk: 15

Company: Edesa Biotech, Inc.
Filing Date: 2025-03-11
Form: 424B3
Chunk 15
---
 meaning of Section 2(11) of the Securities Act will be subject to the prospectus delivery requirements
of the Securities Act.

To the extent required, the Shares or
the Conversion Shares to be sold, the names of the Selling Shareholders, the respective purchase prices and public offering prices, the
names of any agents, dealer or underwriter, any applicable commissions or discounts with respect to a particular offer will be set forth
in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this
prospectus.

In order to comply with the securities
laws of some states, if applicable, the Shares or the Conversion Shares may be sold in these jurisdictions only through registered or
licensed brokers or dealers. In addition, in some states the Shares or the Conversion Shares may not be sold unless it has been registered
or qualified for sale or an exemption from registration or qualification requirements is available and is complied with.

We have advised the Selling Shareholders
that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the market and to the activities
of the Selling Shareholders and their affiliates. In addition, we will make copies of this prospectus (as it may be supplemented or amended
from time to time) available to the Selling Shareholders for the purpose of satisfying the prospectus delivery requirements of the Securities
Act. The Selling Shareholders may indemnify any broker-dealer that participates in transactions involving the sale of the shares against
certain liabilities, including liabilities arising under the Securities Act.

We have agreed to indemnify the Selling
Shareholders against liabilities, including liabilities under the Securities Act and state securities laws, relating to the registration
of the shares offered by this prospectus.

We have agreed with the Selling Shareholders
to keep the registration statement of which this prospectus constitutes a part effective until such time as the Shares or the Conversion
Shares offered by the Selling Shareholders have been effectively registered under the Securities Act and disposed of in accordance with
such registration statement, the Shares or the Conversion Shares offered by the Selling Shareholders have been disposed of pursuant to
Rule 144 under the Securities Act or the shares offered by the Selling Shareholders may be resold pursuant to Rule 144 without restriction
or limitation (including without the requirement to be in compliance with Rule 144(c)(1)) or another similar exemption under the Securities
Act.

| 13 |

### DESCRIPTION OF SECURITIES

#### General
We are authorized